The business of diagnosing and treating ADHD is experiencing “hyperactive growth,” reports Mother Jones. The article points to drug company promotional efforts, expanded diagnostic criteria, the appeal of amphetamines to high-performance cultures globally, and other factors.
Sales of ADHD Meds Are Skyrocketing. Here’s Why. (Mother Jones, February 24, 2015)